My understanding is that was actually the point of having a CDR. Of course, while we wanted expert advice and the best advice to be distributed through a panel such as that, as far as I understood it, the emphasis was on advising the drug plans when to make these financial decisions. In other words, it's cost containment.
On April 30th, 2007. See this statement in context.